Improvement in health care utilization and pulmonary function with fluticasone propionate in patients with steroid-dependent asthma at a National Asthma Referral Center

被引：4

作者：

Wenzel, SE ^{[1
]}

Morgan, K ^{[1
]}

Griffin, R ^{[1
]}

Stanford, R ^{[1
]}

Edwards, L ^{[1
]}

Wamboldt, FS ^{[1
]}

Rogenes, P ^{[1
]}

机构：

[1] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA

来源：

JOURNAL OF ASTHMA | 2001年 / 38卷 / 05期

关键词：

asthma; fluticasone propionate; health care utilization; inhaled corticosteroid; pulmonary function;

D O I：

10.1081/JAS-100001495

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

The impact of switching from other inhaled corticosteroids to fluticasone propionate was studied in patients with severe oral-steroid-dependent asthma over a 1-year period. In this open-label prospective study, patients on maintenance doses of oral and inhaled steroids were referred to a national asthma treatment center and were switched from their previous inhaled corticosteroid to fluticasone propionate 880 mug BID. Compared with data collected from the year prior to enrollment, treatment with fluticasone propionate resulted in significant improvements in pulmonary function, oral steroid requirements, and health resource utilization. In addition, five patients were completely weaned off oral steroids.

引用

页码：405 / 412

页数：8

共 24 条

[1] TRIAL OF CYCLOSPORINE IN CORTICOSTEROID-DEPENDENT CHRONIC SEVERE ASTHMA [J].

ALEXANDER, AG ;

BARNES, NC ;

KAY, AB .

LANCET, 1992, 339 (8789) :324-328

[2]

[Anonymous], 1987, AM REV RESPIR DIS, V136, P225

[3] A placebo-controlled multicenter study of auranofin in the treatment of Patients with corticosteroid-dependent asthma [J].

Bernstein, IL ;

Bernstein, DI ;

Dubb, JW ;

Faiferman, I ;

Wallin, B ;

Bronsky, E ;

Spector, SL ;

Nathan, RA ;

Nelson, HS ;

Bardana, EJ ;

Blumenthal, MN ;

Bone, RC ;

Briggs, DD ;

Busse, WW ;

Campbell, SC ;

Condemi, JJ ;

Crain, MR ;

Grossman, J ;

Handley, GJ ;

Kemp, JP ;

Klaustermeyer, WB ;

Ledford, DK ;

Lockey, RF ;

Lopez, M ;

McNeil, DL ;

Metzger, WJ ;

Montanaro, A ;

Pinnas, JL ;

Schoenwetter, WF ;

Townley, RG ;

Valentine, MD ;

VanArsdel, PP ;

Vari, AJ ;

Weisberg, SC ;

Zeitz, HJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (02) :317-324

[4]

*BUR LAB STAT, 1998, CONS PRIC IND

[5] FLUTICASONE PROPIONATE AEROSOL FOR THE TREATMENT OF ADULTS WITH MILD-TO-MODERATE ASTHMA [J].

CHERVINSKY, P ;

VANAS, A ;

BRONSKY, EA ;

DOCKHORN, R ;

NOONAN, M ;

LAFORCE, C ;

PLESKOW, W .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (04) :676-683

[6]

CRANE M, 1988, MED ECON, P128

[7] A COMPARISON OF QUANTITATIVE ANATOMY OF BRONCHI IN NORMAL SUBJECTS IN STATUS ASTHMATICUS IN CHRONIC BRONCHITIS AND IN EMPHYSEMA [J].

DUNNILL, MS ;

MASSARELLA, GR ;

ANDERSON, JA .

THORAX, 1969, 24 (02) :176-+

[8] LACK OF BENEFIT OF METHOTREXATE IN SEVERE, STEROID-DEPENDENT ASTHMA - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

ERZURUM, SC ;

LEFF, JA ;

COCHRAN, JE ;

ACKERSON, LM ;

SZEFLER, SJ ;

MARTIN, RJ ;

COTT, GR .

ANNALS OF INTERNAL MEDICINE, 1991, 114 (05) :353-360

[9]

Gavin L, 1998, J ALLERGY CLIN IMMUN, V101, pS45

[10] Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids [J].

Johnson, M .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) :169-176

← 1 2 3 →